New Technology, Therapies, eHealth & mHealth Aze Wilson azesuzanne.wilson@lhsc.on.ca 519-663-3832 Affiliation Academic Medical Organization of Southwestern Ontario Richard Kim richard.kim@lhsc.on.ca 519-663-3553 Affiliation Academic Medical Organization of Southwestern OntarioWe evaluated how HLA-DQA1-HLA-DRB1-screening can identify inflammatory bowel disease (IBD) patients at high-risk of azathioprine (AZA)-induced pancreatitis, a severe drug side effect....
AMO-18-005 Enhancing Safety and Benefit from Azathioprine Therapy for Our Inflammatory Bowel Disease Patients
Aze Wilson (pictured) + Richard B. Kim
